NARA Discovery
Article Details
← Back to Search Results
Journal Article

Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study

Wanwan Yi; Xuan Long; Jin Liu; LiShuai Shi; Zichen Chen; Jing Yang; Ziyu Yang; Zhongwei Lv; Hengwei Fan
Human Cell · Vol. 34, Issue 6 · pp. 1744-1754 · 2021

Abstract

Positive retests of COVID-19 represent a public health concern because of the increased risk of transmission. This study explored whether factors other than the nucleic acid amplification test (NAAT) contribute to positive retest results. Patients with COVID-19 admitted to the Guanggu district of the Hubei Maternal and Child Health Hospital between February 17 and March 28, 2020, were retrospectively included. The patients were grouped into the negative ( n = 133) and positive ( n = 51) retest groups. The results showed that the proportion of patients presenting with cough was higher ( P < 0.001) and the proportion of patients with dyspnea was lower ( P = 0.018) in the positive than in the negative retest group. The positive retest group showed shorter durations between symptom onset and hospitalization ( P < 0.001) and symptom onset and the first positive NAAT ( P = 0.033). The positive retest group had higher basophil counts ( P = 0.023) and direct bilirubin ( P = 0.032) and chlorine concentrations ( P = 0.023) but lower potassium concentrations ( P = 0.001) than the negative retest group. Multivariable regression analysis showed that coughing (OR = 7.59, 95% CI 2.28–25.32, P = 0.001) and serum chloride concentrations (OR = 1.38, 95% CI 1.08–1.77, P = 0.010) were independently associated with a positive retest result. Coughing and serum chloride concentrations were independent risk factors for positive NAAT retest results. Patients with a hospital stay of < 2 weeks or a short incubation period should stay in isolation and be monitored to reduce transmission. These results could help identify patients who require closer surveillance.

Bibliographic Information

JournalHuman Cell
PublisherSpringer
Publication Date2021-11-01
Publication Year2021
Volume34
Issue6
Pages1744-1754
Document TypeJournal Article
eISSN1749-0774
DOI10.1007/s13577-021-00618-9

Access Information

NARA Access Coverage2002-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13577
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.